Beacon Clinical Research
Private Company
Total funding raised: $2.5M
Overview
Beacon Clinical Research is a private, service-based contract research organization (CRO) that has been operational since 2005. It generates revenue by providing clinical trial execution services to pharmaceutical and biotechnology sponsors, leveraging its location in a major biotech hub and a track record of hundreds of completed trials. The company operates a single clinical site, focusing on patient recruitment and trial management rather than developing its own therapeutic assets. Its business model is built on offering sponsors access to a skilled investigator team and a compliant, convenient facility for conducting clinical research.
Technology Platform
Operational clinical trial execution platform consisting of a state-of-the-art clinical facility, GCP/IAA-compliant processes, experienced physician investigators, and patient recruitment systems. No proprietary drug discovery or digital health technology.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Beacon competes with other independent clinical research sites, site management organizations (SMOs), and the site networks of large global CROs in the Boston area. Its differentiation is based on its long local tenure, therapeutic area experience, and positioning as a leading independent center, rather than on scale or technology.